Angiotensin II does not affect endothelial tone in Type 1 diabetes-results of a double-blind placebo controlled trial.

about

Angiotensin II does not affect endothelial tone in Type 1 diabetes-results of a double-blind placebo controlled trial.

Item

http://www.wikidata.org/entity/Q46892324

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Angiotensin II does not affect ...... lind placebo controlled trial.

@en

Angiotensin II does not affect ...... lind placebo controlled trial.

@nl

type

Item

label

Angiotensin II does not affect ...... lind placebo controlled trial.

@en

Angiotensin II does not affect ...... lind placebo controlled trial.

@nl

prefLabel

Angiotensin II does not affect ...... lind placebo controlled trial.

@en

Angiotensin II does not affect ...... lind placebo controlled trial.

@nl

P1476

Angiotensin II does not affect ...... lind placebo controlled trial.

@en

P2093

D L Browne

http://www.w3.org/2001/XMLSchema#string

D R Meeking

http://www.w3.org/2001/XMLSchema#string

J L Munday

http://www.w3.org/2001/XMLSchema#string

K M Shaw

http://www.w3.org/2001/XMLSchema#string

M H Cummings

http://www.w3.org/2001/XMLSchema#string

S E Allard

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placement

Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism

Regulation of endothelin-1 production in cultured rat vascular smooth muscle cells.

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases.

Endothelial function. From vascular biology to clinical applications.

Treatment of diabetic nephropathy in its early stages.

Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.

Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.

Effects of chronic subdepressor dose of angiotensin II type 1 receptor antagonist on endothelium-dependent vasodilation in patients with congestive heart failure.

P304

53-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-5491.2005.01727.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16409566

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

placebo